What is Applied BioCode?
Applied BioCode operates as a specialized manufacturer within the in-vitro diagnostics (IVD) sector, focusing on the development and commercialization of multiplex testing solutions. By providing sophisticated assays for gastrointestinal and respiratory pathogens, the company addresses critical needs in both clinical and research laboratory environments. Their proprietary technology is engineered to facilitate high-throughput testing, allowing for the simultaneous detection of multiple pathogens, which significantly enhances laboratory operational efficiency and diagnostic accuracy. Through its commitment to streamlining clinical workflows, Applied BioCode remains a key player in improving patient outcomes and diagnostic throughput.
How much funding has Applied BioCode raised?
Applied BioCode has raised a total of $9.6M across 2 funding rounds:
Private Equity
$9.3M
Debt
$350K
Private Equity (2014): $9.3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in Applied BioCode
PPP
Public-Private Partnership
Undisclosed Private Equity
An investment firm focused on long-term value creation through strategic equity participation in high-growth diagnostic and healthcare technology companies.
Undisclosed Investor
An institutional backer participating in the funding round to support the advancement of multiplex diagnostic technologies.
What's next for Applied BioCode?
With the recent influx of capital, Applied BioCode is well-positioned to scale its enterprise-level operations and expand its footprint in the global diagnostics market. The company is expected to leverage this financing to accelerate the development of its next-generation multiplex panels and further optimize its laboratory instrumentation. As the demand for rapid, high-precision infectious disease testing continues to rise, Applied BioCode's strategic focus on operational efficiency and technological innovation will likely serve as a primary driver for its long-term growth and competitive differentiation in the healthcare technology space.
See full Applied BioCode company page
